Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 1/20 | 0.39 |
| ▸ | FLT3 | P36888 | 2/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.38 |
| ▸ | GSK3A | P49840 | 2/20 | 0.38 |
| ▸ | GSK3B | P49841 | 2/20 | 0.38 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.38 |
| ▸ | RAF1 | P04049 | 1/20 | 0.38 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.38 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.38 |
| ▸ | PRKACA | P17612 | 1/20 | 0.38 |
| ▸ | CDK8 | P49336 | 1/20 | 0.38 |
| ▸ | CLK2 | P49760 | 1/20 | 0.38 |
| ▸ | CDK9 | P50750 | 1/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.38 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19913150 | 0.96 | MAPK14 (0.39) | IMPDH2FLT3MAPK14GSK3AGSK3B | |
| SCHEMBL19919611 | 0.92 | FLT3 (0.42) | FLT3MAPK14GSK3AGSK3BLRRK2 | |
| SCHEMBL19909478 | 0.92 | FLT3 (0.41) | FLT3MAPK14GSK3AGSK3BMAPK13 | |
| SCHEMBL19909476 | 0.91 | AURKA (0.41) | FLT3MAPK14GSK3AGSK3BROCK1 | |
| SCHEMBL19913174 | 0.91 | ABCG2 (0.40) | MAPK14MAPK13RAF1MAPK12MAPK11 | |
| SCHEMBL19908921 | 0.90 | MKNK1 (0.40) | IMPDH2FLT3MAPK14GSK3AGSK3B | |
| SCHEMBL19909119 | 0.90 | FLT3 (0.37) | FLT3MAPK14GSK3AGSK3BCSNK1A1 | |
| SCHEMBL19909164 | 0.90 | USP2 (0.40) | FLT3MAPK14GSK3AGSK3BCLK4 | |
| SCHEMBL19909117 | 0.89 | MAPK14 (0.39) | FLT3MAPK14GSK3AGSK3BCSNK1A1 | |
| SCHEMBL19909350 | 0.89 | MAPK14 (0.39) | IMPDH2FLT3MAPK14GSK3AGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11588114-B2 | Organic molecules for use in optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-02-21 | — | — | US | disclosed |
| US-20200212316-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
| US-10665792-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2020-05-26 | — | — | US | disclosed |
| US-20180062085-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
| US-20180062085-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200212316-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, OPRM1, OR51E2 | IMPDH2 2305/4885FLT3 2571/4885MAPK14 2544/4885 |
| US-10665792-B2 | Organic molecules for use in optoelectronic devices | OR10J3, CFD, AOX1 | IMPDH2 4122/4885FLT3 3269/4885MAPK14 2787/4885 |
| US-11588114-B2 | Organic molecules for use in optoelectronic devices | OR10J3, OPRM1, OR51E2 | IMPDH2 2305/4885FLT3 2571/4885MAPK14 2544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.